New Zealand to India: Device Import Trade Route
India has recorded 11 verified shipments of Device imported from New Zealand, representing a combined trade value of $59.8K USD. This corridor is served by 3 active New Zealand exporters, with an average shipment value of $5.4K USD. The leading New Zealand supplier is AROA BIOSURGERY LTD, which accounts for 57% of total import value with 7 shipments worth $34.1K USD. On the buying side, MORULAA HEALTHTECH PRIVATE LIMITED is the largest Indian importer with $34.1K USD in purchases. The top 3 suppliers — AROA BIOSURGERY LTD, AROA BIOSURGERY LTD. , AROA BIOSURGERY LTD — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill of entry records. Values reported in FOB USD.

Route Intelligence Overview
The New Zealand to India Device corridor is one of India's established pharmaceutical import routes from New Zealand, with 11 shipments documented worth a combined $59.8K USD. The route is dominated by AROA BIOSURGERY LTD, which alone accounts for roughly 57% of all import value, reflecting the consolidated nature of New Zealand's device export sector.
Across 3 active New Zealand suppliers, the average shipment value stands at $5.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 76% of all shipments, consistent with device's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 24 days port-to-port. The route has recorded an annual growth rate of 19.6%, placing it at rank #7 among India's top device import origins globally.
On the Indian buyer side, key Indian importers include MORULAA HEALTHTECH PRIVATE LIMITED, ASIA ACTUAL INDIA (OPC) PRIVATE LIMITED , MORULAA HEALTHTECH PRIVATE LIMITED . MORULAA HEALTHTECH PRIVATE LIMITED is the single largest Indian importer with 7 shipments valued at $34.1K USD.
Route Characteristics
- Average transit24 days
- Peak seasonQ1
- Primary modeSea freight
- Top port of entryCHENNAI AIR CARGO ACC (INMAA4)
Market Position
- Global rank#7
- Annual growth+19.6%
- Demand growth+18.6%
- Regulatory ease78/100
Top 10 Device Exporters from New Zealand to India
Showing top 10 of 3 New Zealand suppliers exporting Device to India, ranked by total trade value (USD)
| Rank | Supplier (New Zealand Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | AROA BIOSURGERY LTD Avg $4.9K per shipment | 7 | $34.1K | 57.0% |
| 2 | AROA BIOSURGERY LTD. Avg $8.1K per shipment | 3 | $24.3K | 40.6% |
| 3 | AROA BIOSURGERY LTD Avg $1.4K per shipment | 1 | $1.4K | 2.3% |
This table shows the top 10 of 3 New Zealand companies exporting device to India, ranked by total trade value. The listed exporters are: AROA BIOSURGERY LTD, AROA BIOSURGERY LTD. , AROA BIOSURGERY LTD . AROA BIOSURGERY LTD is the dominant supplier with 7 shipments worth $34.1K USD, giving it a 57% market share.
Top 10 Indian Device Importers from New Zealand
Showing top 10 of 3 known Indian buyers receiving Device shipments from New Zealand, ranked by import value
On the receiving end of this trade route, the leading Indian importers of New Zealand device include MORULAA HEALTHTECH PRIVATE LIMITED, ASIA ACTUAL INDIA (OPC) PRIVATE LIMITED , MORULAA HEALTHTECH PRIVATE LIMITED . The largest importer is MORULAA HEALTHTECH PRIVATE LIMITED, accounting for $34.1K USD across 7 shipments — representing 57% of all device imports from New Zealand on this route.
| Rank | Indian Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MORULAA HEALTHTECH PRIVATE LIMITED | 7 | $34.1K | 57.0% |
| 2 | ASIA ACTUAL INDIA (OPC) PRIVATE LIMITED | 3 | $24.3K | 40.6% |
| 3 | MORULAA HEALTHTECH PRIVATE LIMITED | 1 | $1.4K | 2.3% |
Top 10 Device Formulations Imported from New Zealand
Showing top 10 of 11 product formulations shipped on the New Zealand to India Device route, ranked by trade value
India imports a wide range of device formulations from New Zealand, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — SR03LG0505US MYRIAD MATRIX 5 X 5 CM, 3 LAYER(MEDICAL DEVICES) — accounts for $16.2K USD across 1 shipments. There are 11 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SR03LG0505US MYRIAD MATRIX 5 X 5 CM, 3 LAYER(MEDICAL DEVICES) | 1 | $16.2K | 27.1% |
| 2 | SR03LG1010US Endoform Myriad 3 Layer 10 x 10cm device Lot SUR-22F01R | 1 | $9.2K | 15.4% |
| 3 | SR03LG1020US Endoform Myriad 3 Layer 10 x 20cm device Lot.SUR-22F02 | 1 | $6.4K | 10.7% |
| 4 | SR03LG1020US MYRIAD MATRIX 10 X 20 CM, 3 LAYER (MEDICAL DEVICES) | 1 | $5.3K | 8.8% |
| 5 | SR03LG1010US Endoform Myriad 3 Layer 10 x 10cm device Lot.SUR-22F01R | 1 | $4.6K | 7.7% |
| 6 | SR03LG0505US Endoform Myriad 3 Layer 5 x 5cm device Lot. SUR-22E04R | 1 | $4.1K | 6.9% |
| 7 | SR03LG0505US Endoform Myriad 3 Layer 5 x 5cm device Lot SUR-22E04R | 1 | $4.1K | 6.8% |
| 8 | SR03LG1010US Endoform Myriad 3 Layer 10 x 10cm device Lot.SUR-22F01R | 1 | $3.6K | 6.1% |
| 9 | 629304 ENDOFORM ANTIMICROBIAL 4 X 5"/10X12.7CM HIGH FLOW(MEDICAL DEVICES) | 1 | $2.8K | 4.7% |
| 10 | SR03LG1020US Endoform Myriad 3 Layer 10 x 20cm device Lot. SUR-22F02 | 1 | $2.1K | 3.4% |
Showing top 10 of 11 Device formulations imported from New Zealand on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 76%, typical for bulk pharmaceutical shipments.
Top Indian Ports of Entry
CHENNAI AIR CARGO ACC (INMAA4) handles the highest volume with 7 shipments. Transit time averages 24 days by sea.
Market Dynamics
India's device imports from New Zealand are driven primarily by a handful of large-scale New Zealand manufacturers. AROA BIOSURGERY LTD with 7 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — Indian buyers benefit from New Zealand supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — AROA BIOSURGERY LTD, AROA BIOSURGERY LTD. , AROA BIOSURGERY LTD — together account for 100% of total trade value on this route. The average shipment value of $5.4K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as sr03lg1010us endoform myriad 3 layer 10 x 10cm device lot sur-22f01r and sr03lg1020us endoform myriad 3 layer 10 x 20cm device lot.sur-22f02 , suggesting that Indian buyers tend to consolidate orders across related product lines from the same New Zealand supplier.
On the buying side, MORULAA HEALTHTECH PRIVATE LIMITED is the largest importer with 7 shipments worth $34.1K USD — representing 57% of all device imports from New Zealand on this route.
Route Statistics
- Trade Volume
- $59.8K
- Avg. Shipment
- $5.4K
- Suppliers
- 3
- Buyers
- 3
- Transit (Sea)
- ~24 days
- Annual Growth
- +19.6%
Unlock the Full New Zealand to India Device Dataset
TransData Nexus provides verified shipment-level records, exporter contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 11 shipments on this route.
Frequently Asked Questions — New Zealand to India Device Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which New Zealand companies export Device to India?
The leading New Zealand exporters of Device to India are AROA BIOSURGERY LTD, AROA BIOSURGERY LTD. , AROA BIOSURGERY LTD . AROA BIOSURGERY LTD holds the largest market share at approximately 57% of total trade value on this route.
Q What is the total value of Device imports from New Zealand to India?
India imports Device from New Zealand worth approximately $59.8K USD across 11 recorded shipments. The average value per shipment is $5.4K USD.
Q Which Indian ports receive Device from New Zealand?
The most active Indian port of entry is CHENNAI AIR CARGO ACC (INMAA4) with 7 shipments. New Zealand exporters primarily use sea freight for this route, with 76% of shipments going by sea and 23% by air.
Q How long does shipping take from New Zealand to India for Device?
The average transit time for Device shipments from New Zealand to India is approximately 24 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the New Zealand to India Device import route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 19.6% with demand growth tracking at 18.6%. The route is ranked #7 among India's top Device import origins globally.
Q How many New Zealand suppliers are active on this Device import route?
There are currently 3 active New Zealand suppliers exporting Device to India. The market is moderately concentrated with AROA BIOSURGERY LTD accounting for 57% of total shipment value.
Q Who are the main Indian importers of Device from New Zealand?
The leading Indian importers of Device from New Zealand include MORULAA HEALTHTECH PRIVATE LIMITED, ASIA ACTUAL INDIA (OPC) PRIVATE LIMITED , MORULAA HEALTHTECH PRIVATE LIMITED . MORULAA HEALTHTECH PRIVATE LIMITED is the largest buyer with 7 shipments worth $34.1K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to New Zealand export trade corridor identified from Indian Customs (DGFT) records for Device.
- 2.Supplier/Buyer Matching: 3 Indian exporters and 3 importers in New Zealand matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 11 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
11 Verified Shipments
3 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists